FDA fast-tracks personalized therapy for hard-to-treat-prostate cancer
A novel combination treatment for advanced prostate cancer has been granted Fast Track status by the FDA. Depositphotos – By Paul McClure 2024 Jul 02 – The US Food and Drug Administration (FDA) has green-lit the fast-tracking of an innovative personalized treatment for advanced …